RM
RAAB MICHAEL Chief Executive Officer
C-suite M
US US · SEC (Form 4)
Discover the detailed record of transactions filed by RAAB MICHAEL, Chief Executive Officer. Insider active across 2 companies, notably Amicus Therapeutics, INC.. In total, 21 reports have been recorded. Total volume traded: €109k. The latest transaction was disclosed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations 21 total
012,671 shares 0
Common Stock
SEC:0001209191-22-035842:0 · 9 Jun 2022
€61,782 101,480 shares @ €0.6088 0.0043% mcap 17.5% of flow
Common Stock
SEC:0001567619-22-012552:0 · 6 Jun 2022
€3,887 6,124 shares @ €0.6347 0.0003% mcap 1.1% of flow
Common Stock
SEC:0001567619-22-011519:0 · 20 May 2022
€68,370 15,000 shares @ €4.558 0.0015% mcap 49.5% of flow
Common Stock
SEC:0001209191-22-027241:0 · 2 May 2022
€3,690 6,229 shares @ €0.5924 0.0003% mcap 1.0% of flow
Common Stock
SEC:0001567619-22-005662:0 · 22 Feb 2022
0150,000 shares 0
Common Stock
SEC:0001567619-22-001136 · 6 Jan 2022
0150,000 shares 0
Common Stock
SEC:0001567619-22-001136:0 · 6 Jan 2022
€2,293 2,607 shares @ €0.8797 0.0002% mcap 1.6% of flow
Common Stock
SEC:0001567619-21-021162 · 22 Nov 2021
€2,293 2,607 shares @ €0.8797 0.0002% mcap 0.6% of flow
Common Stock
SEC:0001567619-21-021162:0 · 22 Nov 2021
0300,000 shares 0
Common Stock
SEC:0001567619-21-019033 · 8 Oct 2021
0300,000 shares 0
Common Stock
SEC:0001567619-21-019033:0 · 8 Oct 2021
€2,909 2,573 shares @ €1.1305 0.0002% mcap 2.1% of flow
Common Stock
SEC:0001567619-21-016284 · 20 Aug 2021
€2,909 2,573 shares @ €1.1305 0.0002% mcap 0.8% of flow
Common Stock
SEC:0001567619-21-016284:0 · 20 Aug 2021
€121,877 267,892 shares @ €0.4549 0.0086% mcap 86.0% of flow
Common Stock
SEC:0001567619-21-014511 · 3 Aug 2021
€121,877 267,892 shares @ €0.4549 0.0086% mcap 34.5% of flow
Common Stock
SEC:0001567619-21-014511:0 · 3 Aug 2021
010,115 shares 0
Common Stock
SEC:0001209191-21-040384 · 10 Jun 2021
010,115 shares 0
Common Stock
SEC:0001209191-21-040384:0 · 10 Jun 2021
€14,691 2,534 shares @ €5.7976 0.0010% mcap 10.4% of flow
Common Stock
SEC:0001567619-21-010922 · 20 May 2021
€14,691 2,534 shares @ €5.7976 0.0010% mcap 4.2% of flow
Common Stock
SEC:0001567619-21-010922:0 · 20 May 2021
€34,844 5,634 shares @ €6.1846 0.0008% mcap 100.0% of flow
Common Stock
SEC:0001209191-21-034478 · 18 May 2021
€34,844 5,634 shares @ €6.1846 0.0008% mcap 25.2% of flow
Common Stock
SEC:0001209191-21-034478:0 · 18 May 2021
About RAAB MICHAEL Michael Raab is an executive at Amicus Therapeutics, Inc.